Abstract: This study aims to optimize the dynamic administration regimen of prophylactic enoxaparin in critically ill patients to reduce the risk of VTE, major bleeding, and 30-day all-cause mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results